Pharmallama

Pharmallama was co-founded in June 2020 by three intelligent minds: Achintya Dayal, Arjun Raghunandan, and Deepesh Rajpal. The company is based in Bangalore and it is India's first full-service digital pharmacy that aims to simplify medical needs. Achintya Dayal, Arjun Raghunandan, and Deepesh Rajpal are Season 2's most technically sophisticated pharmacy automation founders a team that identified India's chaotic household medicine box as a systemic healthcare problem causing medication non-adherence (the most common cause of preventable disease worsening in chronic conditions) and built India's first automated prescription-parsing, medicine-sorting, and sachet-packaging system to solve it.

The founders showed a chaotic medicine box to the Sharks which can be found in every Indian house. The elderly in our families read the prescription of the Doctor daily to take their medicines and try to guess the timing of each medicine. 40% of elderly depend on a caretaker to take their medicines in the right manner, at the right time, and in the right quantity. Pharmallama found an innovative solution to this problem. Many pharmacies in India deliver medicine online, but their service is limited to delivering medicines. Pharmallama takes it one step ahead. The machine understands the prescription with proprietary technology and packs it in small packets and sachets. Every sachet is mentioned with all the details, including name, dose, date, time, and other details.

Amount Asked: ₹1 crore Equity Offered: 1.5% Implied Pre-Money Valuation: ₹66.67 crore

Achintya, Arjun, and Deepesh opened Season 2 Episode 39 with the most universally recognisable Indian household healthcare problem the chaotic medicine box stuffed with strips, bottles, and loose pills that every Indian family with elderly members recognises instantly. Every Shark in the room, and every viewer at home, had personally experienced or witnessed the confusion of trying to manage multiple medications for an elderly parent or grandparent. The live demonstration of the smart sachet system showing a doctor's prescription being uploaded, parsed by the proprietary algorithm, and the medicines being automatically sorted into daily labelled sachets converted the problem statement into an immediately comprehensible solution. Every detail that causes medication errors (which pill, how many, at what time, with or without food) was pre-printed on each sachet, making the medication management decision as simple as reading a label.

Anupam Mittal made the first formal offer of ₹1 crore for 2.22% equity (₹45 crore valuation) acknowledging the product's genuine innovation and the ACG Pam Pac institutional credibility. Namita Thapar was the most domain-aligned Shark Emcure Pharmaceuticals' deep relationships in India's pharmaceutical distribution ecosystem made her the most strategically valuable Shark for a digital pharmacy. Peyush Bansal was the most personally moved Shark declaring Pharmallama his favourite pitch in all of Season 2. His specific appreciation: the combination of technology innovation, social mission. Aman Gupta and Amit Jain both joined the all-Shark coalition without individual exit the unanimous Shark enthusiasm for Pharmallama's concept made a competitive individual offer dynamic unnecessary.

Anupam Mittal first offered to invest ₹1 crore for 2.22% equity, valuing the company at ₹45 crore. The business was also presented with an all-Shark offer of ₹2 crore for 5% equity. After negotiations, the deal closed with all five Sharks investing together: ₹2 crore for 5% equity, implying a valuation of around ₹40 crore. The founders negotiated from a ₹66.67 crore implied valuation (their original ask) to ₹40 crore (the all-Shark deal valuation). In exchange, they received ₹2 crore instead of ₹1 crore and secured all five Sharks simultaneously the most comprehensive Shark coalition in Season 2.

Achintya Dayal, Arjun Raghunandan, and Deepesh Rajpal accepted the all-five-Shark offer of ₹2 crore for 5% equity valuing Pharmallama at ₹40 crore. All five Sharks Namita Thapar, Anupam Mittal, Aman Gupta, Peyush Bansal, and Amit Jain invested together in Season 2's most complete unanimous Shark deal. Despite the historic all-Shark investment, Pharmallama shut down in December 2023 after regulatory challenges from the Delhi Chemists Association challenged the legality of its medicine repackaging operations

By July 2023, Pharmallama announced that they had sent out over 300,000 medicines, which indicated that their business was growing. However, Pharmallama faced some serious problems. The Delhi Chemists Association argued that running an e-pharmacy like Pharmallama is against the law in India. They claimed there are no rules that allow Pharmallama to repackage and sell medicines. The association sent a letter addressing the founders and the Health Ministry, asserting that Pharmallama's operations are illegal and should be shut down. Pharmallama's social media channels went quiet as of July 2023. In December 2023, Medianama confirmed that the company has indeed shut down and ceased their operations.